Sleep in Autism: What to Try, What to Check

Key takeaways

• “Sleep is bad” covers several different problems. Naming yours changes the plan.
• Check breathing, pain, restless legs, seizures, and medicines before settling on a routine.
• The main prolonged-release melatonin trial found about 32 extra minutes of sleep and about 25 minutes less time to fall asleep. The range around that estimate was wide.
• A studied prolonged-release product is not the same as a gummy off a shelf. Most gummies tested in one 2023 study were outside 10% of their labeled amount.
• Adults need adult evidence. CBT-I adapted for autistic adults has direct trial support.
• Judge the morning as well as the night. Falling asleep faster is not a win if the next day is worse.

Zoom

“Sleep is bad” can mean several different problems. One person cannot fall asleep. Another falls asleep easily and wakes for hours. Someone else sleeps too little because work, caregiving, or an early bus leaves too little time in bed. The most useful first step is naming the problem, and what it costs the next day.

A sleep plan should fit the person’s sensory needs, communication, health, and household. It may combine changes to the room, treatment for another condition, and a specific insomnia treatment. Melatonin is one option to discuss in some situations. It is not a substitute for checking breathing problems, pain, seizures, or dangerous daytime sleepiness.

Children and adults need separate evidence and separate plans. A treatment studied in young children does not predict the result for an autistic adult. A parent’s report of a child’s sleep is not the same as an adult’s own experience.

Name the sleep complaint

Try describing the hardest part in ordinary words. Does sleep take a long time to start? Are the awakenings brief or long? Does sleep come much later than the required bedtime? Is there even enough time to sleep? Are breathing, movement, discomfort, or fear breaking up the night?

Circadian delay means the body’s sleep timing runs later than the schedule a person has to keep. That is different from being unable to sleep at any hour. Restless sleep can mean many things: discomfort, movement, breathing trouble, or frequent waking. Heavy daytime sleepiness deserves its own assessment. It should not be called laziness.

You do not need a perfect diary before asking for help. A few estimates and some concrete examples are enough to start. If someone is dangerously sleepy, avoid driving and other hazardous tasks and get clinical advice promptly.

Children and families: start with a plan people can use

The American Academy of Neurology has a sleep guideline for autistic children. It says to check other conditions and medicines first. Then try behavioral sleep strategies. It supports discussing melatonin when those steps have not been enough. Its evidence search ended in 2017, so newer studies belong alongside it. 1

“Behavioral” should not mean leaving a child alone with fear or sensory distress. It can mean making the sequence predictable, changing what happens before bed, and helping caregivers respond in a way they can keep up. A visual plan, a familiar sound, a tolerable fabric, or a clear way to ask for help can make a routine usable.

Start with the actual evening. Is the child hungry, uncomfortable, overstimulated, or unsure what happens next? Is a sibling awake nearby? Does a caregiver work late? Has the routine grown so long that nobody gets enough rest? These are planning facts. They are not proof that a family has failed.

A wind-down should be predictable and tolerable. Think about the timing of light, activity, demanding tasks, and caffeine where relevant. A dark room helps one child and frightens another. A gradual change usually beats a rigid rule the household cannot keep. Discuss medicine timing with the prescriber rather than shifting it yourself.

Give the child a way to say “pain,” “toilet,” “too hot,” “scared,” or “help.” Keep AAC within reach. A child who leaves the bed may be saying something the current plan gives them no other way to say. 2

Caregiver exhaustion belongs in the appointment. Ask what is realistic on a school night, who else can help, and which single change would take away the most burden. A plan that needs hours of work every night may be unrealistic even when each part sounds sensible.

Check the contributors that would change treatment

Snoring with pauses, gasping, or other breathing concerns can point toward obstructive sleep apnea. Constipation, reflux, dental pain, or other discomfort can break up sleep. Anxiety can keep someone alert long past bedtime. Some events raise concern for seizures, especially with altered awareness or a new, unusual pattern. 2

Restless legs involves an uncomfortable urge to move, often worse at rest and eased by moving. Describing that feeling can be hard for a child or for someone with communication differences. When the history suggests it, a clinician may ask about iron status or other contributors. Restless movement alone does not diagnose iron deficiency, and supplements should not be started as a home test.

Not everyone needs a sleep study, an EEG, or blood work. The point is which findings justify which test. Breathing trouble, concerning neurologic events, rapid decline, or immediate safety risks should be handled promptly, not after waiting to see whether a routine works.

Review medicines, supplements, and other substances too. Some delay sleep. Others cause sedation without restorative sleep. Bring the names and how they are actually taken. A useful question is simply: could this be affecting the sleep problem we are seeing?

What the prolonged-release melatonin trial found

A major pediatric trial tested a specific prolonged-release melatonin product in children aged 2 to 17.5 years whose sleep had not improved enough with a behavioral approach. Most participants were autistic. A smaller group had Smith-Magenis syndrome. The trial compared the product with placebo over 13 weeks. 3

The main results came from parent sleep diaries. The adjusted difference favored the product by about 32 minutes of total sleep, and about 25 minutes less time to fall asleep. Those are between-group figures. The larger improvement seen within the treatment group alone also includes changes that happen with time, attention, and placebo.

The uncertainty around the total-sleep figure was wide: roughly 2 to 62 extra minutes. Some children gained much more than others. Usable paired actigraphy data, from a device that estimates sleep through movement, existed for only a small subset. This was not a large objective confirmation of every diary finding.

Sleepiness was reported more often in the treatment group. The manufacturer funded the trial, and some authors had manufacturer relationships. Those facts do not erase the result. They belong in judging how much weight one product-specific study should carry. 3

The trial supports a clinician discussion about falling asleep and total sleep in a selected group of children. It does not show that every night waking responds to melatonin, that melatonin treats sleep apnea, or that all autistic children need it.

A studied product is not any gummy on a shelf

The trial used a defined prolonged-release formulation in a research setting. Release pattern and product quality matter. A U.S. over-the-counter gummy or tablet is not the same intervention just because the package says melatonin.

In the United States, dietary supplements sit under a different framework from approved drugs. FDA does not approve supplements for safety and effectiveness before they are sold. That is not the same as saying supplements are unregulated. 4

A 2023 laboratory study tested 25 melatonin gummy products bought for that study. Most did not contain melatonin within 10% of the labeled amount. That was a snapshot of sampled products. It is not a current ranking of brands or a test of every batch. It shows why a trial cannot tell you what is inside an unrelated product bought online. 5

Discuss the reason for use, the formulation, product quality, other medicines, and follow-up with a clinician. Store melatonin securely and away from children, especially products that look like candy. “Natural” does not mean free of side effects or interactions. This article gives no dose, schedule, or shopping list. 6

What longer follow-up can tell us

A follow-up study of the prolonged-release product observed children for roughly two years. It did not find a clear signal of delayed growth or puberty among those assessed. But the long-term phase was not a continuing placebo comparison. Some participants left. Puberty was assessed in only a small subgroup. 7

That is reassuring, with limits. It is not proof of lifelong safety, and it is not proof that developmental effects are impossible. It also does not show that melatonin causes developmental harm. The honest summary is that long-term evidence remains incomplete.

If treatment helps, keep asking whether it still helps, whether daytime function is better, and whether side effects or new contributors have appeared. No family should be left with an open-ended supplement recommendation and no plan to reassess.

Adults: your own sleep problem needs its own plan

Autistic adults may face sensory discomfort, delayed sleep timing, anxiety, pain, work schedules, caregiving, or years of advice that failed. Start with the same four questions. Is there enough time to sleep? Is sleep hard despite having the time? Is the timing wrong? Or is there a medical sleep disorder?

Cognitive behavioral therapy for insomnia, or CBT-I, works on the processes that keep insomnia going. It is more than a list of sleep-hygiene tips. Several changes can make it work better for an autistic adult. Written explanations. Sessions that follow the same shape each time. Concrete goals. Sensory changes to the room. A diary that is easy to fill in. A pace that leaves room for questions. A trusted supporter can join if the person wants that.

A July 2026 randomized trial tested guided online CBT-I adapted with autistic input. It included 163 autistic adults and compared the program with a waiting-list group that received information. Insomnia symptoms improved more with the program. Sleep gains held at follow-up, but the trial did not find clear improvement in anxiety, depression, or daily functioning. Only about half completed every module. 8

That is useful direct adult evidence. It also has limits. The comparison group did not get an equally intensive therapy. The available abstract also does not show the program fits every language, thinking, or communication profile. An online program that helps selected adults is not always reachable for someone who needs a great deal of daily support.

A 2025 review found promising CBT-I results across neurodevelopmental groups, but the studies varied widely and many lacked a randomized comparison. The review covered ADHD as well as autism, and children as well as adults. Its pooled numbers should not be presented as hundreds of autistic adults getting the same treatment. 9

Ask for adaptation rather than assuming the only options are following a protocol exactly or giving up. If a diary becomes overwhelming, agree on fewer useful observations. If the bedroom is the only quiet space you have, say so before being told to use it only for sleep.

Some CBT-I plans adjust time in bed. Do not cut your time in bed sharply on your own. That is riskier with bipolar disorder, with seizure risk, or when daytime sleepiness is already dangerous. Tell the clinician, so the plan can be adapted. Improving sleep should not create a new safety problem.

There is far less melatonin research in autistic adults than in children. A child trial cannot give an adult response rate. It cannot pick the right product for an adult either. The diagnosis, the sleep complaint, other conditions, and the person’s preferences should drive the discussion.

Judge the morning as well as the night

Better sleep should improve something that matters: comfort, alertness, learning, work, mood, or the household’s ability to function. A person may fall asleep faster and feel worse the next day. Another may still wake briefly and feel rested and less distressed. Ask the person, not only the clock.

Questions worth bringing:

• Which sleep problem are we treating, and what other cause should we check?
• Which change fits my sensory needs and what our household can manage?
• If melatonin is being considered, how does the evidence fit this age and this formulation?
• How will we review next-day function, side effects, and whether it is still needed?

Frequently asked questions

Is melatonin safe for my autistic child? That is a decision for your child’s clinician, based on the reason for use, other conditions, and other medicines. The best-studied product is a specific prolonged-release formulation, and the trial ran 13 weeks. Long-term evidence is incomplete.

Are melatonin gummies the same as what was studied? No. A 2023 study of 25 gummy products found most were outside 10% of their labeled amount. Formulation and release pattern both matter.

My child snores loudly. Does that change anything? Yes. Snoring with pauses or gasping can point toward obstructive sleep apnea, which needs its own assessment. Raise it before starting any sleep routine or supplement.

Does sleep hygiene work for autistic adults? Sleep hygiene alone is usually not enough for insomnia. CBT-I addresses what keeps insomnia going, and there is now direct trial evidence in autistic adults.

Should I try restricting time in bed? Not on your own. Sleep restriction can be risky with bipolar disorder, seizure risk, or dangerous sleepiness. Do it only with a clinician.

Related reading on NP FADY

• When anxiety narrows an autistic life
• Autistic burnout and depression
• Missed conditions and medication targets

References

1. Williams Buckley A, Hirtz D, Oskoui M, et al. Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020;94:392–404. DOI 10.1212/WNL.0000000000009033. DOI.

2. Hyman SL, Levy SE, Myers SM; Council on Children With Disabilities, Section on Developmental and Behavioral Pediatrics. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics. 2020;145:e20193447. DOI 10.1542/peds.2019-3447. DOI.

3. Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2017;56:948–957.e4. DOI 10.1016/j.jaac.2017.09.414. DOI.

4. U.S. Food and Drug Administration. FDA 101: Dietary Supplements (Consumer Update). Silver Spring, MD: FDA. Accessed September 2026. Source.

5. Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329:1401–1402. DOI 10.1001/jama.2023.2296. DOI.

6. National Center for Complementary and Integrative Health. Melatonin: What You Need To Know. Bethesda, MD: NCCIH; updated May 2024. Accessed September 2026. Source.

7. Malow BA, Findling RL, Schroder CM, et al. Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2021;60:252–261.e3. DOI 10.1016/j.jaac.2019.12.007. DOI.

8. Spaargaren KL, Begeer S, Nieuwenhuis S, et al. Effectiveness of guided internet-delivered cognitive behavioral therapy for insomnia in autistic adults (i-Sleep Autism): a randomized controlled trial. Sleep. 2026;zsag199. DOI 10.1093/sleep/zsag199. DOI.

9. Cullen MC, McCrory S, Hooman G, et al. Effectiveness of Cognitive Behavioural Therapy for Insomnia (CBT-I) in Individuals With Neurodevelopmental Conditions: A Systematic Review. Journal of Sleep Research. 2025;34:e70058. DOI 10.1111/jsr.70058. DOI.

---

This article is for education. It does not diagnose a condition, replace individual care, or promise services. Do not start, stop, or change any medicine without your prescribing clinician. Reading this does not create a clinician-patient relationship. Evidence checked September 8, 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.